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Sexual activity and functioning in women treated for gynaecological
cancers
Ragnhild Johanne Tveit Sekse, Karl Ove Hufthammer and Margrethe Elin Vika
Aims and objectives. A description and comparison of sexual activity and func-
tion in relation to various gynaecological cancer diagnoses, treatment modalities,
age groups, psychological distress and health-related quality of life.
Background. Various forms of gynaecological cancer have the potential to nega-
tively influence sexual functioning, but there are few studies that describe and
compare sexual activity and functioning according to diagnosis.
Design. A descriptive cross-sectional study.
Methods. The study includes 129 women from an intervention study. The ques-
tionnaires addressed sexuality, psychological distress, health-related quality of life
and demographics. Disease and treatment characteristics were extracted from
medical records.
Results. Close to two-thirds of the women were sexually active. However, 54%
of the sexually active women reported that they were not satisfied or little satis-
fied with their sexual activity. About half of the women reported dryness in the
vagina, and 41% reported pain and discomfort during penetration. There were
no significant differences concerning pleasure and discomfort related to treatment
modality, diagnoses or FIGO stage.
Conclusion. Health personnel should make a priority of sexuality throughout a
patient’s cancer treatment and in the follow-up, as sexuality is a vital part of a good life.
Relevance to clinical practice. Since the patients experience relatively low satisfac-
tion with their sexual activity and many report pain during penetration, health
personnel need to be sensitive to the woman, her questions, and her needs. Of
importance are also the personnel’s ability to communicate and their expertise in
diagnosing and treating difficulties relating to sexuality.
Key words: follow-up, gynaecological cancer, quality of lifesexual activity, sexual
functioning
What does this paper contribute
to the wider global clinical
community?
• More than 50% of the women
are not satisfied with their sexual
activity after treatment for gyne-
cological cancer
• About half of the women report
dryness in vagina
• The women have a high score on
pain and discomfort related to
sexual activity
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Introduction
Background
Improved treatment methods, in addition to a higher inci-
dence of cancer and an ageing population, have resulted in
an increase in the number of gynaecological cancer sur-
vivors. Consequently, there is also an increasing population
of survivors suffering from side-effects of cancer treatment
(Juraskova et al. 2003, Jensen et al., 2003; Frumovitz et al.
2005, Mercadante et al. 2010, Lind et al. 2011, Lam-
merink et al. 2012).
The adverse effects on women’s sexuality caused by the
cancer treatment have been a focus of attention lately
(Bergmark et al. 1999, Liavaag et al. 2008, Greimel et al.
2009, Hersch et al. 2009, Grover et al. 2012, Vaidakis
et al. 2014). Ovarian, cervical, endometrial and vulvar can-
cers all have the potential to negatively influence sexual
functioning, but there are few studies that describe and
compare sexual activity and functioning according to diag-
nosis. The ongoing debate, however, is the discussion of
different treatment options on sexual functioning outcomes,
particularly after radiation and/or chemotherapy (Greimel
et al. 2009, Korfage et al. 2009, Cleary & Hegarty 2011).
Regardless of diagnosis and treatment of cancer in the
female genital organs, each stage of the sexual response
cycle may be affected: sexual desire, arousal and orgasm
(Audette & Waterman 2010, Lammerink et al. 2012). For
instance, 33 of the 34 studies in a review (Abbott-Anderson
& Kwekkeboom 2012) identified physical concerns among
the gynaecological cancer survivors, for example, concerns
of pain during intercourse, lubrication, vaginal dryness and
vaginal atrophy.
Despite the connection between physical changes and
sexuality, research on gynaecological cancer and sexuality
has been criticised for its unilateral focus on physical
aspects (Cleary & Hegarty 2011) and its lack of a holistic
perspective. Sexuality is an integral part of human life and,
as such, fundamental to a person’s health. Sexuality and
sexual well-being are thus complex phenomena, involving
all aspects of a person’s life (Hordern 2008, Sekse et al.
2010, Cleary et al. 2011, Gilbert et al. 2011, Abbott-
Anderson & Kwekkeboom 2012). In addition to the physi-
cal sequelae following gynaecological cancer, the women’s
sexuality may also be negatively affected, due to psycholog-
ical factors. Their QoL and well-being may be negatively
affected by anxiety, depression, psychological distress,
changes in femininity and body-image (Juraskova et al.
2003, Reis et al. 2010, Cleary & Hegarty 2011, Gilbert
et al. 2011, Abbott-Anderson & Kwekkeboom 2012, Sekse
et al. 2012).
Moreover, side-effects like fatigue and poor QoL may
affect the ability and desire for sexual activity(Stead et al.
2007, Greimel et al. 2009, Grover et al. 2012, McCallum
et al. 2012, Carter et al. 2013). Not surprisingly, the effects
of cancer and its treatment also had an adverse effect on
intimacy and physical relationships (Ratner et al. 2010,
Abbott-Anderson & Kwekkeboom 2012). Many women,
for example, fear that intercourse may be painful (Abbott-
Anderson & Kwekkeboom 2012).
Summing up, gynaecological cancer and its treatment
might affect women both physically, psychologically, socially
and existentially, and, by that, their quality of life and sexual
life. This study’s purpose was a description and comparison
of sexual activity and functioning of the various gynaecologi-
cal cancers according to diagnosis, treatment modality and
age. Secondly, we wanted to investigate the relationship
between sexual activity and functioning according to psycho-
logical distress and health-related quality of life.
Methods
Participants
This study was part of a larger randomised controlled study
with two test groups (educational and a physical training
group), carried out between 2009 and 2012. The women
were contacted mainly by mailed letters, from three differ-
ent hospitals in Norway. The participants were selected
based on the following criteria: female; having completed
curative treatment, independent of type of gynaecological
cancer and FIGO stage; age >18 years; able to walk on a
treadmill; and agreement to participate, as specified by
informed written consent. Exclusion criteria: significant
amnesic symptoms. A total of 129 women were included in
the study.
Data collection
Psychometric instruments that measure sexuality, anxiety,
depression, fatigue and health-related quality of life were
used to assess the women. A questionnaire specifically made
for the main study was used for demographic data (age,
level of education, marital status and employment status).
Diagnostic and treatment information was gathered from
the respondents’ medical records.
The Sexual Activity Questionnaire (SAQ) is a self-report
questionnaire consisting of three sections covering (1)
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relational status, (2) reasons for sexual inactivity and (3)
sexual functioning (SAQ-F) (Thirlaway et al. 1996).
The first section, relational status, assess whether women
are sexually active or not. The sexually inactive have to
complete section 2 and omit section 3. The second section
contains eight possible reasons for being sexually inactive.
Sexually active women complete section 3, which assesses
sexual functioning that may be influenced by hormonal sta-
tus: desire, frequency, satisfaction, dryness of vagina and
penetration pain. The sexual functioning (SAQ-F) has a
time frame of last month, and consists of 10 items. Items
1–7 of the SAQ-F are rated on a four-point scale from ‘very
much’ to ‘not at all’. We used a modified version of a Nor-
wegian translation of the SAQ, where these seven items
were instead rated ‘yes’ or ‘no’. The SAQ discomfort items
concerns ‘dryness of the vagina’ and ‘pain and discomfort
at penetration.’ The SAQ pleasure items comprised the
items “Was ‘having sex’ an important part of your life this
month?”, ‘Did you enjoy having sex this month?’, ‘Did you
desire to have sex with your partner last month?’, ‘In gen-
eral, were you satisfied with your sexual activity last
month?’, ‘How often did you engage in sexual activity last
month?’, and ‘Were you satisfied with the frequency of sex-
ual activity last month?’. Note that some of the questions
differ somewhat in meaning from the questions in the origi-
nal SAQ in Thirlaway et al. (1996).
The Hospital Anxiety and Depression Scale (HADS) is a
14-item, 4-point ordinal response questionnaire for measur-
ing symptoms of anxiety and depression in a nonpsychiatric
context. Seven items measure anxiety, and seven items mea-
sure depression, with higher scores reflecting higher symp-
tom loads. The questionnaire has shown good reliability
and validity in primary care and in clinical populations
(Bjelland et al. 2002), and has also been used in relation to
gynaecological cancer (Liavaag et al. 2009).
The Fatigue Questionnaire (FQ) (Chalder et al. 1993)
contains 11-items measuring fatigue intensity during the
preceding month. We used a modified version, translated
into Norwegian. (Cella & Chalder 2010). The translation
has previously been used in a large population survey in
Norwegian (Loge et al. 1998a).
SF-36 is multidomain questionnaire measuring general
health, and is not age, disease or treatment specific (Ware
& Sherbourne 1992). The response options vary from yes/
no to answers on ordinal response scales. The measure con-
tains eight individual subscales: physical functioning (10
items), physical role limitations (4 items), bodily pain (2
items), general health (5 items), energy/vitality (4 items),
social functioning (2 items), emotional role limitations (3
items) and mental health (5 items). The eight dimension
scores were transformed into scales from 0 (poorest/worst
health) to 100 (best health). The psychometric properties
are well recognised, also in Norwegian studies (Loge et al.
1998a,b).
Ethical considerations
The regional Committee for Medical Research Ethics
(2009/895) approved the study, and all participants gave
their written consent.
Data analysis
Data were stored in an SPSS data file (IBM Corp., Armonk,
NY, USA), and analysed using R version 3.1.1 (R Core
Team 2013). Categorical data were analysed using cross-
tabulation and Fisher’s exact test. Continuous data were
compared using Welch’s two-sample t-test. Ordinal data
were compared using the exact Mann–Whitney–Wilcoxon
test. The results are reported as means, 95% confidence
intervals, counts and percentages, along with p-values. In




Of the 129 women (mean age 57, SD 13, range 28–81),
76% were married or lived in a paired relationship. Forty-
four per cent had attended college/university. Half the
women (52%) were employed and a quarter (26%) were
retired (Table 1).
Diagnosis and treatment characteristics
The mean follow-up time since diagnosis was 16 months
(SD 9, range 1–38). The cancer diagnoses were uterine can-
cer 45%, ovarian cancer 28%, cervical cancer 24% and
vulvar cancer 3% (Table 1). The FIGO stages were stage I
(69%), stage II (11%), stage III (17%) and stage IV (3%)
(Table 1). Most of the women (94%) were treated with
surgery, and 47% were treated with surgery only, while
49% also received adjuvant chemotherapy. A total of 15%
received radiation treatment.
Sexually active vs. sexually inactive
Of the 129 women, 78 were in a sexual relationship, 42
were not and 9 chose not to respond to this question. The
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Table 1 Distribution of patient characteristics and treatment-related factors of sexually active and inactive cancers survivors
n




Total sample (n = 120)
Mean or
count SD or perc.
Mean or
count SD or perc.
Mean or
count SD or perc.
Age at survey 78/41 53 12 61 13 0001 56 13
Civil status
Paired relation 78/40 72 92% 18 45% <0001 90 76%
Single 2 3% 8 20% 10 8%
Divorced 4 5% 7 18% 11 9%
Widowed 0 0% 7 18% 7 6%
Living with children
under 18 years
78/41 27 35% 7 17% 006 34 29%
Educational level
Elementary school 78/41 5 6% 5 12% 006* 10 8%
Secondary school 33 42% 22 54% 55 46%
College/university 40 51% 14 34% 54 45%
Employment status
Employed 78/42 51 65% 15 36% <0001 66 55%
Unemployed 9 12% 5 12% 14 12%
Retired 8 10% 20 48% 28 23%
Disability pension 3 4% 2 5% 5 4%
Homemaker 5 6% 0 0% 5 4%
Other 2 3% 0 0% 2 2%
Regular physical activity
7 times a week or more 78/38 3 4% 2 5% 085* 5 4%
4–6 times a week 16 21% 9 24% 25 22%
2–3 times a week 29 38% 12 32% 41 36%
Once a week 21 27% 7 18% 28 24%
Once a month 3 4% 2 5% 5 4%
Less than once a month 2 3% 5 13% 7 6%
Never 3 4% 1 3% 4 3%
Time from diagnosis to
survey (months)
78/48 166 86 161 10 077 165 91
Diagnosis
Uterine cancer 78/42 35 45% 18 43% 099 53 44%
Ovarian cancer 22 28% 13 31% 35 29%
Cervical cancer 19 24% 10 24% 29 24%
Vulvar cancer 2 3% 1 2% 3 2%
FIGO stage
I 74/41 50 68% 29 71% 052* 79 69%
II 7 9% 6 15% 13 11%
III 13 18% 6 15% 19 17%
IV 4 5% 0 0% 4 3%
Treatment modality
Surgery only 76/42 37 49% 19 45% 098 56 47%
Surgery and chemotherapy 26 34% 17 40% 43 36%
Surgery, chemotherapy and radiation 5 7% 3 7% 8 7%
Chemotherapy and radiation 4 5% 2 5% 6 5%
Surgery and radiation 2 3% 1 2% 3 3%
Chemotherapy only 2 3% 0 0% 2 2%
Fatigue (bimodal sum score) 75/36 41 34 41 36 091 41 35
Anxiety (HADS score) 76/41 48 36 54 35 026 5 36
Depression (HADS score) 77/42 29 29 38 4 015 32 34
Recidivism 75/39 8 11% 8 21% 017 16 14%
*P-value based on the exact Mann–Whitney–Wilcoxon test.
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most frequent reason for being sexual inactive were ‘no
partner’ (50%), ‘not interested in sex’ (19%) and ‘partner
not interested in sex’ (12%) (Fig. 1). One fourth of the
women (24%) had multiple reasons for being sexual inac-
tive, while 14% did not state any reason.
Marital status and education
The differences in marital status between sexually active
and inactive women are shown in Table 1. Of the sexually
active women 92% were married or lived in a paired rela-
tion, compared to 45% of the sexually inactive women.
The sexually active women were on average younger
(53 years compared to 61 years; p = 0002) than the inac-
tive women (Table 1, Fig. 4). Sexually active women had
higher education (although not statistically significant,
p = 006). There was also a positive association between
having high(er) education and enjoying having sex
(p = 002), and with feeling satisfied with one’s sexual
activity (p = 004), but not for the other SAQ pleasure
questions.
Diagnosis, quality of life and psychological distress
There were no differences in the proportion of sexually
active women with different diagnoses (all proportions
between 62% and 67%, p = 095), and no association
between being sexually active and FIGO stage, time since
diagnosis (161 months vs. 166 months), treatment modali-
ties, anxiety or depression (HADS), fatigue (FQ) or fre-
quency of physical activity per week.
There was little difference in quality of life as measured
by SF-36 between sexually active and inactive women
(Fig. 2). The only statistical significant difference was on
the subscale Physical functioning, where sexually active
women reported better quality of life (mean scores of 87
and 81, respectively, p = 002). Most of this difference was
due to a greater proportion of sexually active women
with the very highest scores of 95 and 100 (52% of the sex-




Of the sexually active women 89% (64/72) were engaged
in sexual activity at least once in the preceding month, 1–2
times (36%), 3–4 times (25%) and 5 or more times (28%).
There were no differences in frequency of sexual activity
according to age, diagnosis, FIGO stage or treatment
method (Table 2). In women reporting being sexually
active, nearly 51% reported the frequency of sexual activity
the preceding month to be about the same as was usual,
while 35% reported a lower frequency.
Sexual pleasure and activity
Of the sexually active women 24% (17/71) were not satis-
fied with their sexual activity, 30% were a little satisfied,
38% somewhat satisfied and 8% very much satisfied. There
were no differences related to the items measuring pleasure
according to age group, diagnosis, FIGO stage or treat-
ment.
Dryness, pain and discomfort during sexual activity
Half of the sexually active women reported vaginal dryness,
70%, 50%, 33% and 0% of the women treated for ovar-
ian, uterine, cervical and vulvar cancer respectively
(p = 006).
About 41% of the sexually active women reported pain
or discomfort during penetration (Fig. 3), 50, 41, 27 and
50% of the women treated for ovarian, uterine, cervical
and vulvar cancer respectively. The differences were not
statistically significant (p = 052).
There were no significant differences in mean age for the
proportion responding ‘yes’ on the seven yes/no items.
However, there was a higher proportion responding that
they had noticed dryness in vagina for the middle age group
(age 50–65), 72%, compared to 20% in the older group
and 43% in the younger group (p = 001). The women in
the middle age group also reported more pain and discom-
fort during penetration, 60%, compared to 9% in the older
group and 35% in the younger group (p = 0009). There
Figure 1 Women’s self-reported reasons for
not being sexually active (n = 142) (It was
possible to state more than one reason).
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were no significant differences in reports of discomfort
associated with treatment or FIGO stage.
Discussion
As far as we know, no other study offers a detailed descrip-
tion of sexual functioning and activity in women treated
for different kinds of gynaecological cancers. Our results
indicate that sexual activity decreases with age. This is in
line with Vistad et al. (2007a), who reported a decrease
in sexual activity with increasing age. Furthermore, women
in our study are less sexually active compared to the nor-
mative sample in Vistad’s study (2007a). Still, nearly two-
thirds of the women had participated in sexual activity the
Figure 2 Scores on the eight quality of life domains of the self-report scale SF-36 in sexually active (n = 61–78) and not sexually active
(n = 25–42) women. Higher values indicate better quality of life. The dots have been jittered to reduce the effect of overplotting. The mean
values are shown as vertical lines.
Table 2 Distribution of engagement in sex-
ual activity according to age, diagnosis,
FIGO stage and treatment modality
n








≤50 72 3 9% 14 40% 8 23% 10 29% 089
50–65 3 12% 7 28% 8 32% 7 28%
>65 2 17% 5 42% 2 17% 3 25%
Diagnosis
Uterine cancer 72 6 19% 11 34% 8 25% 7 22% 038
Ovarian cancer 1 5% 7 35% 5 25% 7 35%
Cervical cancer 0 0% 8 44% 5 28% 5 28%
Vulvar cancer 1 50% 0 0% 0 0 1 50%
FIGO stage
I 68 4 9% 18 38% 13 28% 12 26% 038
II 0 0 2 33% 3 50% 1 17%
III 2 18% 4 36% 0 0% 5 45%
IV 0 0% 1 25% 1 25% 2 50%
Treatment modality
Surgery only 71 3 8% 15 42% 6 17% 12 33% 024
Surgery and chemotherapy 3 13% 8 35% 6 26% 6 26%
Surgery, chemotherapy
and radiation
0 0 1 20% 4 80% 0 0%
Chemotherapy and
radiation
0 0 1 33% 1 33% 1 33%
Surgery and radiation 1 50% 0 0% 0 0% 1 50%
Chemotherapy only 1 50% 1 50% 0 0% 0 0%
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month before, more than in other similar samples. For
example, in a study by Liavaag et al. (2008) approximately
one in two ovarian cancer survivors (n = 189) were sexu-
ally active, and Vistad et al. (2007b) showed that 30% of
the cervical cancer survivors were sexually active during the
last month.
The women in this study reported a lower level of sexual
pleasure and a higher level of discomfort compared to a
normative sample (Vistad et al. 2007a). Over half of the
sexually active women were not satisfied or little satisfied
with their sexual activity. Also, about half of the women
reported vaginal dryness. The percentage varied among
women with ovarian cancer (70%), uterine cancer (50%)
and cervical cancer (33%). Overall 41% of the sexually
active women reported pain or discomfort during penetra-
tion. A negative impact on sexual functioning over time in
women who have had gynaecological cancer is also well
documented (Bergmark et al. 1999, Stewart et al. 2001,
Park et al. 2007, Sekse et al. 2010). Lack of sexual interest,
physical problems and fear of pain during intercourse are
some of the difficulties mentioned. For example, in a study
of disease-free long-term survivors (n = 860) with a history
of cervical cancer, participants reported reduced sexual
functioning and performance compared to healthy controls
(Park et al. 2007). In a review (Abbott-Anderson &
Kwekkeboom 2012), physical concerns, vaginal dryness
and pain was a deterrent to participating in sexual activity.
However, despite findings in our study and some other
studies that reveal pain and discomfort (which comprise
sexual activity), women’s sexual activity appears to be very
similar to healthy controls’, even in a long-term perspective
(Bergmark et al. 1999). How are we to understand this?
One perspective might be that the women have a desire to
maintain their sexual lives, and to have the same level of
intimacy with their partners as before cancer diagnosis and
treatment. This might be explained by their wish to main-
tain their sexual life primarily to satisfy their partners
rather than themselves (Bergmark et al. 1999). In a qualita-
tive study by Juraskova et al. (2003) the findings revealed
that intimacy rather than physical acts of sexual intercourse
was desired by the women, but was not sufficient to satisfy
their partners. Some women may thus set aside their own
needs to resume their normal lives. Nevertheless, it is rea-
sonable to assume that pain during sex reduces the
women’s pleasure. The somewhat low frequencies of sexual
activity in our study should thus be seen in the light of the
women’s challenges following gynaecological cancers.
Even though there is debate and conflicting opinion with
regard to what treatment options are more detrimental to
sexuality following gynaecological cancer, several studies
have found that sexual problems are particularly related to
adjuvant radiotherapy and chemotherapy (Hawighorst-
Knapstein et al. 2004, Korfage et al. 2009, Lind et al.
2011, Lammerink et al. 2012). One might expect that
women treated with radiation and/or chemotherapy would
report lower levels of ‘pleasure’ and higher levels of ‘dis-
comfort’. Surprisingly, this study found no significant differ-
ences on pleasure and discomfort related to treatment
modality, diagnosis or FIGO stage. Our results correspond
with recent studies that have found no significant differ-
ences in sexual functioning related to adjuvant therapy
compared to those with main treatment (Becker et al.
2011, Nout et al. 2011, Onujiogu et al. 2011). For exam-
ple, Nout et al. (2011) reported that there was no signifi-
cant difference in sexual morbidity between the (n = 246)
endometrial cancer survivors who received external beam
radiotherapy and those who received no adjuvant therapy.
Many of the sexually inactive women were older (Fig. 4).
This is also in line with other studies (Carmack Taylor
et al. 2004, Lai et al. 2009). In contrast, Bifulco et al.
(2012) found that out of (n = 263) early stage gynaecologi-
cal cancer survivors (divided into two groups, older and
younger than 45 years) younger women were significantly
more affected by impaired sexuality. The study showed that
the younger women had less sexual activity than midlife
adults, suffered more from poor body image, perceived
poorer sexual vaginal functioning and had more severe
menopausal symptoms. Although the age groups are not
directly comparable, this seems to be in contrast with Vis-
tad et al. (2007b) study, where a higher proportion of the
Figure 3 Sexually active women’s self-
reported sexual functioning the preceding
month (n = 70–75).
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women in the middle age group (age 50–65) reported dry-
ness in vagina and more pain and discomfort during pene-
tration. In the normative study by Vistad et al. (2007a,b)
the oldest age group reported significantly less pleasure and
more discomfort compared to the younger women. The old-
est age group (age 56–69) in Vistad’s study was younger
than in our study (age 66–81), which may indicate even
greater differences in discomfort when comparing the two
studies. One explanation may be that the oldest women in
the present study have been through a normal menopause
and become accustomed to dryness and other ailments
before treatment for gynaecological cancer, while the mid-
dle age group may have experienced being thrown into a
more severe menopause because of the cancer treatment.
We found that a majority of survivors after various types
of gynaecological cancer and treatment modalities reported
a relatively satisfactory quality of life, despite bodily ail-
ments, discomforts and changes in sexual life. This finding
is also echoed in other studies on gynaecological cancer
(Harter et al. 2013), also in a long-term perspective (Ste-
wart et al. 2001). To understand this, researchers have
interpreted it partly in light of ‘response shift’ (Sprangers &
Schwartz 1999). Sprangers and Schwartz (1999) states that
a person’s values will most likely be affected following a
serious illness. The response shift involves a shift in per-
sonal standards, values and perception of quality of life.
What is regarded as important in life may change after sur-
viving a life-threatening illness. According to many studies,
women seem to experience a positive shift in their perspec-
tives on life, side-effects notwithstanding, after gynaecologi-
cal cancer, and feel enriched. (Ponto et al. 2010, Sekse
et al. 2010, Stewart et al. 2001). The women may have
experienced a change in priorities that partially compen-
sates for other, more negative, changes. As such, the
women’s sense of loss concerning sexual functioning may
change after cancer illness (Stewart et al. 2001, Harter
et al. 2013).
Study limitations
The study had a relatively small sample (N = 129), with
even fewer participants qualified to complete all sections of
the questionnaire. There were only three women diagnosed
with vulvar cancer, and the study is thus not representative
of all women facing type of cancer. Since we have no data
related to the sexuality of the women prior to cancer diag-
nosis and treatment, we cannot draw strong conclusions on
the longitudinal effect of gynaecological cancer and cancer
treatment on sexual activity and functioning.
Furthermore, the results may not apply to the general
population of survivors of gynaecological cancer, as the
sample consisted of women who had already agreed to take
part in an extensive intervention study.
The focus of the questionnaire used in this study was sex-
ual function and activity. Sexuality is certainly a more com-
plex phenomenon than what is reflected through those
aspects, and a study would benefit from a broader
approach. The negative effects of gynaecological cancer and
its treatment are likely to be recognised also in the psycho-
logical and social aspects of sexuality and quality of life. A
broader perspective by adding a qualitative element, for
example, open-ended questions, to the survey, may be one
way to explore the phenomenon to a wider extent. This
could also lead to improved nursing care and practice.
Figure 4 Dot plot showing age distribution of the sexually and not sexually active women (n = 119). The mean ages are shown as vertical
lines.
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Conclusion
This study shows that although women after gynaecological
cancer are sexually active, more than 50% are not satisfied
or little satisfied with this part of their life. They also report
high scores on pain and discomfort related to sexual activ-
ity. Sexuality is a significant part of a woman’s life, and
health personnel should address the issue during treatment
and follow-up.
Relevance to clinical practice
Health personnel should develop a greater understanding of
the challenges cancer poses to a woman’s sexuality, and
should address these in any interaction with the patients,
considering sexual function, response cycle, body image
and sexual relationships. The personnel’s ability to commu-
nicate and their expertise in diagnosing and treating diffi-
culties relating to sexuality are important. Furthermore, any
counselling consultation on the issue should also be accom-
panied by written information to ensure that the informa-
tion is received by the patient.
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